Bitter Crystals  (New label) (The Aloe Collection)
Buy Today
Bitter Crystals  (New label) (The Aloe Collection)
Click to enlarge image(s)

This is the same product just different labels.  We had a new protocol instituted recently and the manufacturer had to relabel the products. Aloe ferox bitters is traditionally used for the beneficial effect it has on symptoms of constipation, eczema, pain due to arthritis and high blood pressure.

Constipation causes harmful toxins to build up in the body. Toxins, that are not properly excreted,
can be absorbed again, leading to poor health:

• colon cancer and diverticulitis are the results of incessant constipation
• chronic constipation may be linked to breast cancer
• treating constipation can prevent appendicitis
• pressure during constipation is responsible for hiatus hernia, varicose veins and haemorrhoids.

Aloe ferox bitters contain plant chemicals that
+ are bacteria, virus and parasite unfriendly
+ help pain to fade away
+ help to detoxify and support disinfection
+ favour an anti-inflammatory action
+ help to prevent constipation.

Laxative: Take 50-300 mg crystals in single dose at night. The smallest dose necessary to maintain
regular bowel movement should be taken.
Other uses: Take 50 mg bitter crystals daily with meals.
A crystal of 50 mg is approximately the size of a match head.
Larger crystals can easily be crushed into smaller crystals.

one or two crystals can be dissolved into Aloe Tea and consumed as a tonic.

For your comfort Bitter Crystals is also available in tablet/capsule form as Fabulous Fibre Bitter.

Safety: Do not use Aloe ferox bitters in cases of intestinal
blockage, acute inflamed intestinal disease (e.g. Crohn’s disease,
ulcerative colon inflammation), appendicitis, abdominal pain of
unknown origin, pregnancy and breastfeeding.

Active ingredients:

Dried crystallized Aloe Bittersap  20 gr / .09 oz

It is clinically proven that the use of anthranoid laxatives (such as
Aloe ferox bitters), even in the long term, DO NOT CAUSE CANCER
(ref. Department of Medicine, Univ of Erlangen, Germany; Journal:
Gut; May 2000; vol 46(5): p 651-5)